Intensivists frequently encounter coagulation abnormalities in critically ill patients. One of the more common etiologies is from massive blood loss. Current management strategies include higher transfusion ratios and new drugs that either increase clotting or decrease fibrinolysis. This article will review the pathophysiology and treatment options for the patient with a coagulopathy from massive transfusions.
WalshTSStanworthSJPrescottRJLeeRJWatsonDMWyncollD. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med. 2010;38:1939-1946.
2.
MacLeodJBLynnMMcKenneyMGCohnSMMurthaM. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39-44.
3.
LierHBöttigerBWHinkelbeinJKrepHBernhardM. Coagulation management in multiple trauma: a systematic review. Intensive Care Med. 2011;37:572-582.
4.
HoffmanMMonroeDM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007;21:1-11.
5.
LeviMSchultzM. Coagulopathy and platelet disorders in critically ill patients. Minerva Anestesiol. 2010;76:851-859.
6.
TripodiAPrimignaniMChantarangkulV. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137:2105-2111.
7.
TripodiACaldwellSHHoffmanMTrotterJFSanyalAJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther. 2007;26:141-148.
8.
ChakravertyRDavidsonSPeggsKStrossPGarrardCLittlewoodTJ. The incidence and cause of coagulopathies in an intensive care population. Br J Haematol. 1996;93:460-463.
9.
DuchesneJCHuntJPWahlG. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years?J Trauma. 2008;65:272-276.
10.
Huber-WagnerSQvickMMussackT. Massive blood transfusion and outcome in 1062 polytrauma patients: a prospective study based on the Trauma Registry of the German Trauma Society. Vox Sang. 2007;92:69-78.
11.
CohenMJBrohiKGanterMTManleyGTMackersieRCPittetJF. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma. 2007;63: 1254-1261.
12.
HarrJNMooreEEWohlauerMV. The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength [published online ahead of print April 17, 2011]. J Surg Res. R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAIBRAA7 doi:10.1016/j.jss.2011.03.047.
13.
BolligerDGorlingerKTanakaKA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology. 2010;113:1205-1219.
14.
BrohiKCohenMJGanterMT. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211-1217.
15.
HeiniusGHahnRGSondenA. Hypothermia increases rebleeding during uncontrolled hemorrhage in the rat. Shock. 2011;36:60-66.
16.
BorgmanMASpinellaPCPerkinsJG. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805-813.
17.
SperryJLOchoaJBGunnSR. An FFP:PRBC transfusion ratio ≥1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65:986-993.
18.
Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198-208.
19.
RossaintRBouillonBCernyV. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52.
20.
HolcombJBWadeCEMichalekJE. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447-458.
21.
ZinkKASambasivanCNHolcombJBChisholmGSchreiberMA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197:565-570.
22.
JohanssonPIStensballeJ. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets—a review of the current literature. Transfusion. 2010;50:701-710.
23.
Rahe-MeyerNPichlmaierMHaverichA. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth. 2009;102:785-792.
24.
LeissingerCABlattPMHootsWKEwensteinB. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol. 2008;83:137-143.
25.
SchöchlHNienaberUHoferG. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55.
26.
MonroeDMHoffmanMOliverJARobertsHR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 1997;99:542-547.
27.
KenetGWaldenREldadAMartinowitzU. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet. 1999;354:1879.
28.
BoffardKDRiouBWarrenB. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8-15.
29.
HauserCJBoffardKDuttonR. Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69:489-500.
30.
CRASH-2 trial collaborators, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23-32.
31.
Marti-CarvajalAJPérez-RequejoJL. Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease. Cochrane Database Syst Rev. 2007;(1):CD006007. doi:10.1002/14651858.CD006007.
